These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

95 related articles for article (PubMed ID: 24142749)

  • 1. Long-term follow-up of mesh-covered stent implantation in patients with ST-segment elevation myocardial infarction.
    Dudek D; Dziewierz A; Kleczyński P; Giszterowicz D; Rakowski T; Sorysz D; Rzeszutko Ł; Legutko J; Bartuś S; Dragan J; Klecha A; Siudak Z; Żmudka K
    Kardiol Pol; 2014; 72(2):140-5. PubMed ID: 24142749
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Mesh-covered embolic protection stent implantation in ST-segment-elevation myocardial infarction: final 1-year clinical and angiographic results from the MGUARD for acute ST elevation reperfusion trial.
    Dudek D; Dziewierz A; Brener SJ; Abizaid A; Merkely B; Costa RA; Bar E; Rakowski T; Kornowski R; Dressler O; Abizaid A; Silber S; Stone GW
    Circ Cardiovasc Interv; 2015 Feb; 8(2):e001484. PubMed ID: 25603802
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Prospective, Randomized, Multicenter Evaluation of a Polyethylene Terephthalate Micronet Mesh-Covered Stent (MGuard) in ST-Segment Elevation Myocardial Infarction: The MASTER Trial.
    Stone GW; Abizaid A; Silber S; Dizon JM; Merkely B; Costa RA; Kornowski R; Abizaid A; Wojdyła R; Maehara A; Dressler O; Brener SJ; Bar E; Dudek D
    J Am Coll Cardiol; 2012 Nov; 60(19):1975-84. PubMed ID: 23103033
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Rationale and design of the MGuard for acute ST elevation reperfusion MASTER trial.
    Costa JR; Abizaid A; Dudek D; Silber S; Leon MB; Stone GW
    Catheter Cardiovasc Interv; 2013 Aug; 82(2):184-90. PubMed ID: 23008177
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [MGuard Dacron mesh-covered stent implantation in patients with ST-elevation myocardial infarction and high thrombotic burden: in-hospital and long-term outcome in a single high-volume center].
    Cerrato E; Rolfo C; Tomassini F; Montali N; Gambino A; Infantino V; Palacio Restrepo S; Baricocchi D; Nevola R; Gagnor A; Varbella F
    G Ital Cardiol (Rome); 2015 Jun; 16(6):373-9. PubMed ID: 26156698
    [TBL] [Abstract][Full Text] [Related]  

  • 6. MGuard mesh-covered stent for treatment of ST-segment elevation myocardial infarction with high thrombus burden despite manual aspiration.
    Romaguera R; Gómez-Hospital JA; Sánchez-Elvira G; Gómez-Lara J; Ferreiro JL; Roura G; Gracida M; Homs S; Teruel L; Cequier A
    J Interv Cardiol; 2013 Feb; 26(1):1-7. PubMed ID: 23419104
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Microvascular coronary flow comparison in acute myocardial infarction angioplasty treated with a mesh covered stent (MGUARD stent) versus bare metal stent: MICAMI-MGUARD.
    Lindefjeld DS; Guarda E; Méndez M; Martínez A; Pérez O; Fajuri A; Marchant E; Aninat M; Torres H; Dussaillant G
    Cardiovasc Revasc Med; 2013; 14(1):4-8. PubMed ID: 23337378
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A prospective, postmarket study with the Mguard Prime Embolic Protection Stent in ST-segment elevation myocardial infarction: the International MGuard Prime Observational Study (IMOS Prime).
    Amoroso G; Vos NS; Van der Heyden JA; van der Schaaf RJ; Patterson MS; Vink MA; Herrman JP; Slagboom T
    Catheter Cardiovasc Interv; 2015 Oct; 86 Suppl 1():S28-33. PubMed ID: 25754236
    [TBL] [Abstract][Full Text] [Related]  

  • 9. MGUard versus bAre-metal stents plus manual thRombectomy in ST-elevation myocarDial infarction pAtieNts-(GUARDIAN) trial: study design and rationale.
    Cassese S; Esposito G; Mauro C; Varbella F; Carraturo A; Montinaro A; Cirillo P; Galasso G; Rapacciuolo A; Piscione F
    Catheter Cardiovasc Interv; 2012 Jun; 79(7):1118-26. PubMed ID: 22105879
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Mesh covered stent in ST-segment elevation myocardial infarction.
    Dudek D; Dziewierz A; Rzeszutko Ł; Legutko J; Dobrowolski W; Rakowski T; Bartus S; Dragan J; Klecha A; Lansky AJ; Siudak Z; Zmudka K
    EuroIntervention; 2010 Nov; 6(5):582-9. PubMed ID: 21044911
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Long-term outcome after drug-eluting versus bare-metal stent implantation in patients with ST-segment elevation myocardial infarction: 5 years follow-up from the randomized DEDICATION trial (Drug Elution and Distal Protection in Acute Myocardial Infarction).
    Holmvang L; Kelbæk H; Kaltoft A; Thuesen L; Lassen JF; Clemmensen P; Kløvgaard L; Engstrøm T; Bøtker HE; Saunamäki K; Krusell LR; Jørgensen E; Tilsted HH; Christiansen EH; Ravkilde J; Køber L; Kofoed KF; Terkelsen CJ; Helqvist S
    JACC Cardiovasc Interv; 2013 Jun; 6(6):548-53. PubMed ID: 23683734
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Impact of thrombus burden on outcomes after standard versus mesh-covered stents in acute myocardial infarction (from the MGuard for acute ST elevation reperfusion trial).
    Costa RA; Abizaid A; Lotan C; Dudek D; Silber S; Dizon JM; Maehara A; Dressler O; Brener SJ; Stone GW
    Am J Cardiol; 2015 Jan; 115(2):161-6. PubMed ID: 25465924
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Efficacy of an Embolic Protection Stent as a Function of Delay to Reperfusion in ST-Segment Elevation Myocardial Infarction (from the MASTER Trial).
    Dudek D; Brener SJ; Rakowski T; Dziewierz A; Abizaid A; Silber S; Yaacoby E; Dizon JM; Costa RA; Maehara A; Dressler O; Stone GW
    Am J Cardiol; 2014 Nov; 114(10):1485-9. PubMed ID: 25277335
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Multicentre experience with MGuard net protective stent in ST-elevation myocardial infarction: safety, feasibility, and impact on myocardial reperfusion.
    Piscione F; Danzi GB; Cassese S; Esposito G; Cirillo P; Galasso G; Rapacciuolo A; Leosco D; Briguori C; Varbella F; Tuccillo B; Chiariello M
    Catheter Cardiovasc Interv; 2010 Apr; 75(5):715-21. PubMed ID: 19937780
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Deferred versus conventional stent implantation in patients with ST-segment elevation myocardial infarction (DANAMI 3-DEFER): an open-label, randomised controlled trial.
    Kelbæk H; Høfsten DE; Køber L; Helqvist S; Kløvgaard L; Holmvang L; Jørgensen E; Pedersen F; Saunamäki K; De Backer O; Bang LE; Kofoed KF; Lønborg J; Ahtarovski K; Vejlstrup N; Bøtker HE; Terkelsen CJ; Christiansen EH; Ravkilde J; Tilsted HH; Villadsen AB; Aarøe J; Jensen SE; Raungaard B; Jensen LO; Clemmensen P; Grande P; Madsen JK; Torp-Pedersen C; Engstrøm T
    Lancet; 2016 May; 387(10034):2199-206. PubMed ID: 27053444
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Long-term outcome after drug-eluting versus bare-metal stent implantation in patients with ST-segment elevation myocardial infarction: 3-year follow-up of the randomized DEDICATION (Drug Elution and Distal Protection in Acute Myocardial Infarction) Trial.
    Kaltoft A; Kelbaek H; Thuesen L; Lassen JF; Clemmensen P; Kløvgaard L; Engstrøm T; Bøtker HE; Saunamäki K; Krusell LR; Jørgensen E; Tilsted HH; Christiansen EH; Ravkilde J; Køber L; Kofoed KF; Terkelsen CJ; Helqvist S
    J Am Coll Cardiol; 2010 Aug; 56(8):641-5. PubMed ID: 20688033
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Long-term effects of drug-eluting stents versus bare metal stents on patients with acute ST-elevation myocardial infarction undergoing primary percutaneous coronary intervention: outcomes of 3-year clinical follow-up.
    Wang CH; Fang Q; Zhang SY; Shen ZJ; Fan ZJ; Jin XF; Zeng Y; Liu ZY; Xie HZ; Yang M
    Chin Med J (Engl); 2012 Aug; 125(16):2803-6. PubMed ID: 22932070
    [TBL] [Abstract][Full Text] [Related]  

  • 18. 5-year follow-up after primary percutaneous coronary intervention with a paclitaxel-eluting stent versus a bare-metal stent in acute ST-segment elevation myocardial infarction: a follow-up study of the PASSION (Paclitaxel-Eluting Versus Conventional Stent in Myocardial Infarction with ST-Segment Elevation) trial.
    Vink MA; Dirksen MT; Suttorp MJ; Tijssen JG; van Etten J; Patterson MS; Slagboom T; Kiemeneij F; Laarman GJ
    JACC Cardiovasc Interv; 2011 Jan; 4(1):24-9. PubMed ID: 21251625
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Drug-eluting versus bare-metal stents in large coronary arteries of patients with ST-segment elevation myocardial infarction: findings from the ICAS registry.
    Abe D; Sato A; Hoshi T; Maruta S; Misaki M; Kakefuda Y; Watabe H; Hiraya D; Sakai S; Kawabe M; Takeyasu N; Aonuma K
    J Cardiol; 2014 Nov; 64(5):377-83. PubMed ID: 24685689
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Long-term comparison of sirolimus-eluting and bare-metal stents in ST-segment elevation myocardial infarction.
    Wijnbergen I; Tijssen J; Brueren G; Peels K; van Dantzig JM; Veer MV; Koolen JJ; Michels R; Pijls NH
    Coron Artery Dis; 2014 Aug; 25(5):378-83. PubMed ID: 24736301
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.